Diligence memo · auto-generated · as of July 2, 2026
Bio-Path Holdings Inc
Bio-Path Holdings Inc looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Bio-Path Holdings Inc operates in Biotechnology, based in BELLAIRE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Bio-Path Holdings Inc has raised $20M in disclosed capital across 13 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $4.0M on 2024-06-03.
Most recent recorded round closed around 2024-10-08.
Valuation (modeled)modeled
Provath models Bio-Path Holdings Inc at approximately $17M (range $2.9M–$41M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.17× the median modeled value of Seed Biotechnology companies in 2022–2024 (207 peers) — value vs value, same stage and era. Within the normal band (117% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 11 months.
Last raise 21 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 1.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 67% of Biotechnology peers (4293 compared).
Modeled value ranks above 26% of those peers.
Closest niche peers: Mesentech Inc., Marlinspike Therapeutics, Inc., Microbial Machines, Inc., Pearl Diagnostics, Inc., Crossfire Medical Inc.
Peoplefiled
13 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.